🧪 Beta — BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

OX2R

MOLECULAR TARGET

Orexin receptor type 2

30 compounds

OX2R (Orexin receptor type 2) is targeted by 30 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting OX2R

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1bdb 1r 5r 2 7 fluoroquinazolin 2 yl 2 6 diazabicyclo 3 2 2 nonan 6 yl 5 methyl 2 2h 0.691
2bdb 1r 5s 3 7 fluoroquinazolin 2 yl 3 6 diazabicyclo 3 2 2 nonan 6 yl 5 methyl 2 2h 0.691
3bdb 1s 5r 3 7 fluoroquinazolin 2 yl 3 6 diazabicyclo 3 2 2 nonan 6 yl 5 methyl 2 2h 0.691
4bdb 1s 5s 2 7 fluoroquinazolin 2 yl 2 6 diazabicyclo 3 2 2 nonan 6 yl 5 methyl 2 2h 0.691
5bdb chembl35979670.691
6bdb chembl35979680.691
7bdb chembl40702750.691
8bdb chembl40762620.691
9bdb chembl4094071 us10377763 example 350.691
10bdb chembl40989480.691
11bdb chembl42031710.691
12bdb chembl42080450.691
13bdb chembl42139740.691
14bdb chembl42153620.691
15bdb chembl44421270.691
16bdb chembl44489490.691
17bdb chembl44540880.691
18bdb chembl44560120.691
19bdb chembl44571940.691
20bdb chembl44678580.691
21bdb chembl45883270.691
22bdb r s 2 2h 1 2 3 triazol 2 yl phenyl 2 5 trifluoromethyl pyridin 2 yl oxy 7 azabic0.691
23bdb us9475819 11 us9062078 11 us9695183 12b us9062078 12b us9062078 12a us9637496 120.691
24bdb us9475819 1810.691
25bdb us9475819 182 us9062078 181 us9695183 183b us9062078 182 us9062078 183a us9062070.691
26bdb us9475819 196 us9062078 196 us9695183 196 us9637496 1960.691
27bdb us9475819 211 us9062078 211 us9695183 211 us9637496 2110.691
28bdb us9475819 221 us9062078 221 us9695183 221 us9637496 2210.691
29bdb us9475819 30 us9062078 30 us9695183 30 us9637496 300.691
30bdb us9475819 32 us9062078 32 us9695183 32 us9637496 320.691

About OX2R as a Drug Target

OX2R (Orexin receptor type 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 30 compounds with documented OX2R interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

OX2R inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.